Use of Idarucizumab to Revert the Anticoagulant Effect of Dabigatran in Heart Transplant Surgery: An Institutional Experience

Heart transplant is a surgical procedure with a high risk of perioperative bleeding in patients with a previous history of sternotomy, congestive liver disease, and/or use of oral anticoagulants. Anticoagulation is usually done with coumarin agents (warfarin, acenocoumarol), while on the waiting lis...

Descripción completa

Detalles Bibliográficos
Autores principales: Herrera-Escandón, Álvaro, Castaño-Cifuentes, Orlando, Plata-Mosquera, Carlos A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7081017/
https://www.ncbi.nlm.nih.gov/pubmed/32206355
http://dx.doi.org/10.1155/2020/6927423

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7081017/
https://www.ncbi.nlm.nih.gov/pubmed/32206355
http://dx.doi.org/10.1155/2020/6927423

Ejemplares similares